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ABSTRACT
Xeroderma pigmentosum (XP) is a group of genetic dis-
orders caused by mutations of XP-associated genes,
resulting in impairment of DNA repair. XP patients fre-
quently exhibit neurological degeneration, but the
underlying mechanism is unknown, in part due to lack of
proper disease models. Here, we generated patient-
speciﬁc induced pluripotent stem cells (iPSCs) harboring
mutations in ﬁve different XP genes including XPA, XPB,
XPC, XPG, and XPV. These iPSCs were further differen-
tiated to neural cells, and their susceptibility to DNA
damage stress was investigated. Mutation of XPA in
either neural stem cells (NSCs) or neurons resulted in
severe DNA damage repair defects, and these neural
cells with mutant XPA were hyper-sensitive to DNA
damage-induced apoptosis. Thus, XP-mutant neural cells
represent valuable tools to clarify the molecular mecha-
nisms of neurological abnormalities in the XP patients.
KEYWORDS xeroderma pigmentosum, iPSC, disease
model, neural stem cell, neuron
INTRODUCTION
Xeroderma pigmentosum (XP) is the ﬁrst discovered rare
autosomal recessive genetic disorder associated with
defective repair of damaged DNA (Cleaver, 1968; Epstein
et al., 1970). XP is divided into eight complementation
groups (XP-A to XP-G, and XP-V) that are associated with
mutations in eight genes (Fassihi, 2013; De Weerd-Kastelein
et al., 1972). XP patients bear molecular defects either in
nucleotide excision repair (NER) or in translesion synthesis
(TLS). NER is involved in the erasure of ultraviolet (UV)-
induced DNA lesions or chemical-caused DNA bulky
adducts (Cleaver et al., 2009). Two most common lesions
induced by UV exposure are cyclobutane pyrimidine dimers
(CPDs) and (6-4) pyrimidine pyrimidinone photoproducts
(6-4 PPs) (Setlow and Setlow, 1962). There are approxi-
mately 30 proteins involved in the NER pathway, including
XPA to XPG. Mechanistically, XPC-HR23B and CSA-CSB
complexes ﬁrst recognize the damaged sites in the genome
and at actively transcribed genes respectively, recruit XPA to
further conﬁrm, and then XPB and XPD as two helicases
unwind the DNA double strands. Subsequently the damaged
sites are removed by the endonuclease XPG and XPF.
Finally, the gap is repaired by DNA polymerase and DNA
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ligase (Scharer, 2013; Mocquet et al., 2008). In TLS, XPV
encodes DNA polymerase η that is responsible for bypass-
ing unrepaired lesions during DNA replication (Cleaver,
1972; Masutani et al., 1999; Chou, 2011). Dysfunction of
these XP proteins results in impairment of DNA repair,
leading to genomic instability and increased tumor inci-
dence, esp. on skins (Robbins et al., 1974). Importantly,
most patients in groups XPA, XPB, XPD, and XPG also
exhibit progressive neurological degeneration (Grewal,
1991; Kulkarni and Wilson, 2008), characterized by micro-
cephaly, dementia, peripheral neuropathy, and sensorineural
hearing loss (Lai et al., 2013; Hayashi et al., 2004; Anttinen
et al., 2008). Of note is that these neurological symptoms are
most frequently observed in XPA patients (Maeda et al.,
1994). While mice deﬁcient in XPA have been created, they
did not recapitulate the neurological degeneration pheno-
types observed in humans (Nakane et al., 1995). The failure
of mouse XPA model calls for a relevant human model
system for disease mechanistic studies.
The advent of induced pluripotent stem cell (iPSC) tech-
nology has opened an unprecedented avenue to study the
mechanism of rare human genetic diseases, including those
caused by defects in DNA damage repair machineries
(Cockayne syndrome (Andrade et al., 2012), Fanconi ane-
mia (Liu et al., 2014), Werner syndrome (Shimamoto et al.,
2014; Cheung et al., 2014)). So far, an iPSC disease model
for XP is still lacking and the establishment of which will
facilitate the understanding of pathogenic mechanism, i.e. in
nervous system. In this study, we established a series of XP-
speciﬁc iPSCs carrying different pathogenic mutations in XP
genes, which were generated from XP patients’ skin ﬁbrob-
lasts. We observed that XPA-mutant neural stem cells
(NSCs) and differentiated neurons were defective in NER
and very vulnerable to DNA damage stress. Our study pro-
vides for the ﬁrst time molecular clues underlying the neu-
rodegeneration observed in XPA patients.
RESULTS
Generation of non-integrative iPSCs from XP patients
We obtained 5 lines of human primary ﬁbroblasts from XPA,
XPB, XPC, XPG, and XPV patients, respectively. DNA
sequencing analysis veriﬁed the presence of mutations in
corresponding XP genes (Fig. 1A and 1B). To generate
patients-speciﬁc iPSCs, we electroporated integration-free
episomal vectors expressing reprogramming factors Oct4,
Sox2, Klf4, L-myc, Lin28, and sh-p53 into ﬁbroblasts and
induced them back to pluripotent state (Okita et al., 2011). All
these XP gene-mutant ﬁbroblasts were capable of being
efﬁciently reprogrammed to iPSCs (Fig. 2A–F), despite the
fact that XPC was reported as an Oct4/Sox2 coactivator by
forming a protein complex in embryonic stem cells (Cattoglio
et al., 2015). In addition, an iPSC line reprogrammed from
healthy (WT) human ﬁbroblasts was used as a control (Ding
et al., 2015). All the derived iPSCs exhibited normal
karyotype and expressed comparable levels of the pluripo-
tency markers including NANOG, OCT4, and SOX2 (Fig. 2C
and 2E). We did not detect any residual episomal repro-
gramming vectors in these iPSC lines (Fig. 2D). Upon being
implanted subcutaneously into immunocompromised mice,
these iPSCs formed teratomas comprised of cells from three
germ lineages (Fig. 2F). Together, these results indicated
that despite XPA, XPB, XPC, XPG, and XPV’s roles in
safeguarding genome stability, mutations in these genes did
not compromise somatic cellular reprogramming as well as
pluripotency of generated iPSCs (Fig. 6).
XPA-mutant NSCs demonstrated impaired DNA repair
potential and increased susceptibility to apoptosis
XP patients frequently exhibit symptoms of neurodegenera-
tion, likely due to increased DNA damage in neural cells. We
ﬁrstly differentiated these iPSCs into NSCs (Fig. 3A and 3B).
Both WT and XP mutant NSCs exhibited typical neural pro-
genitor morphology, expressed neural stem cell-speciﬁc
markers NESTIN and PAX6 (Fig. 3B), and could be further
differentiated into neurons expressing TUJ1 and micro-
tubule-associated protein 2 (MAP2) (Fig. 3C).
Next, we investigated whether mutations in XP genes
could affect DNA repair ability in NSCs. UV radiation causes
DNA damage by introducing CPDs and 6-4 PPs into the
genome, which can be repaired via NER or TLS. Considering
that normal human cells are able to repair 50% of CPDs within
24 h after UV irradiation (Nakagawa et al., 1998), we decided
to employ CPD as an indicator for cellular repair activity. To
this end, we challenged XP-mutant and WT-NSCs with 1 J/m2
UV, and determined the cellular CPD levels. Both WTand XP-
mutant NSCs showed low levels of CPD at the rested state,
which became strongly upregulated 20 min after UV treatment
(Fig. 4A). WT-NSCs demonstrated a strong self-repair activity
as the CPD dropped to basal levels 48 h after UV irradiation.
In contrast, XP-mutant NSCs showed more CPD-positive
cells compared to WT cells 48 h after treatment (Fig. 4A). Of
note is that XPA-mutant NSCs exhibited an unusual high level
of CPD 48 h after UV treatment (Fig. 4B). These observations
indicated that mutations of XP genes resulted in compromised
NER or TLS abilities, and XPA mutation led to most severe
DNA repair defects in NSCs.
We next investigated whether compromised DNA dam-
age repair in XPA mutant NSCs could be associated with
decreased cellular survival. To this end, we treated cells with
1 J/m2 UV, and cellular apoptosis was determined after 24 h.
We found that UV radiation resulted in massive cellular
apoptosis indicated by Annexin V/PI staining in XPA-mutant
NSCs while had little impact on WT-NSCs (Fig. 4C). Western
blotting analysis showed increased levels of cleaved PARP
(c-PARP), an apoptosis marker, in XPA mutant NSCs upon
UV treatment (Fig. 4D). Additionally, terminal deoxynu-
cleotidyl transferase (TdT)-mediated dUTP nick-end labeling
(TUNEL) assay revealed more dramatic nuclear DNA
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fragmentation in XPA mutant NSCs following UV treatment
(Fig. 4E). Additionally, we also observed that the XPA mutant
NSCs had impaired abilities of clonal expansion and
migration even in absence of UV radiation (Fig. 4F and 4G).
Altogether, these ﬁndings indicated a defective NER
system as well as decreased cellular migration and clonal
expansion in XPA-mutant NSCs, and under DNA damage
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Figure 1. Genotyping ﬁbroblasts from ﬁve XP patients. (A) Schematic diagram of NER pathway in the nucleus. Upon DNA
damage, XPC and HR23B recognize damage site, XPA veriﬁes, XPB and XPD unwind DNA double strands, ﬁnally XPF and XPG
excise the damaged strand. All of these proteins function together to repair UV-induced DNA damage. GGR: Global genome repair;
TCR: Transcription-coupled repair. (B) DNA sequencing showing the different mutations in XPA, XPB, XPC, XPG, XPV genes in
ﬁbroblasts from ﬁve XP patients. Fibroblasts isolated from a healthy individual were used as a control.
RESEARCH ARTICLE Lina Fu et al.










































































































































XPA-iPS XPB-iPS XPC-iPS XPG-iPS XPV-iPSWT-iPS

















Neurological pathologies with patients-derived iPSCs RESEARCH ARTICLE









XPA-mutant neurons are defective in NER
and susceptible to UV-induced apoptosis
We next investigated whether post-mitotic neurons with XPA
mutation also exhibited similar defective DNA repair phe-
notypes. For this purpose, we differentiated WT and XPA
mutant NSCs into neurons, respectively (Fig. 5A). Similar to
NSCs, mutation of XPA in neurons resulted in a compro-
mised DNA repair ability, indicated by signiﬁcantly higher
CPD levels upon UV treatment (Fig. 5B). Consistently, XPA-
mutant neurons exhibited more TUNEL-positive cells than
their WT counterparts (Fig. 5C). These results indicated
XPA-mutation compromised neuron’s ability to repair DNA
damage triggered by UV irradiation, and as a result apop-
tosis occured in XPA-mutant neurons (Fig. 6).
DISCUSSION
Neurological abnormalities are observed in patients from
certain xeroderma pigmentosum complementation groups
including XPA, XPB, XPD, and XPG. However, the under-
lying pathogenesis basis is unclear. A roadblock to the
mechanistic understanding in part can be attributed to the
inability of existing XP mouse models to replicate the neu-
rological pathologies of XP patients (Nakane et al., 1995;
Andressoo et al., 2009). Therefore, a more relevant model
system recapitulating human XP pathogenesis is needed for
studying the disease mechanism and developing related
therapy.
Here, we generated for the ﬁrst time transgene-free
iPSCs from ﬁbroblasts of ﬁve XP patients bearing mutations
in XPA, XPB, XPC, XPG, and XPV genes, respectively.
While mutations of DNA repair-related genes (i.e. WRN
(Shimamoto et al., 2014; Cheung et al., 2014) and Fanconi
genes (Raya et al., 2009; Muller et al., 2012; Yung et al.,
2013)) have been revealed as a barrier to somatic cell
reprogramming, we did not observe obvious impairment in
reprogramming kinetics from XP patient ﬁbroblasts. Addi-
tionally, it has recently been reported that mutations of
Fanconi genes compromised the teratoma formation efﬁ-
ciency (Yung et al., 2013), and deﬁciency of FANCA gene in
NSCs resulted in defective neuronal differentiation ability
(Liu et al., 2014). In our study, these XP gene mutant iPSCs
still retained potentials to differentiate to three germ layers,
including NSCs and neuronal cells. In line with these
observations, XP gene mutations did not markedly affect the
chromosomal stability, and the basal CPD levels are com-
parable between XP cells and WT cells.
Regarding the novel disease phenotypes in neural cells,
we observed that mutations of XPA in patients lead to the
most severe defects in NER, compared to the cells with
other XP mutations. This is consistent with the observation
that the patients with XPA mutation(s) more frequently
exhibited neurological abnormalities. In the clinic, XPA
patients showed mild to severe neuronal loss in various brain
regions, including cerebral cortex, brainstem, and spinal
cord (Hayashi et al., 2004). We found that the compromised
NER activity not only inﬂuences the survival of the non-di-
viding neurons but also promotes apoptosis of dividing
neural stem cells. Therefore, the neurodegenerative phe-
notypes observed in XPA patients may be attributed to
decreased cellular survival in both NSCs and neurons upon
DNA damage, as accelerated apoptosis in either NSCs or
neurons could contribute to diminished number or dysfunc-
tion of mature neuronal cells, leading to neurodegeneration.
Besides neurological defects, the XP patients also
demonstrated UV-associated dysfunction of skin cells, i.e.
increased incidence in skin cancers. Thus the skin cell
derivatives derived from XP patient iPSCs can potentially be
used as a platform to study the mechanism of UV-associated
malignant cell transformation. Moreover, combined with tar-
geted gene editing techniques(Liu et al., 2011b; Suzuki et al.,
2014), iPSC-derived neural or skin cells free of pathogenic
mutations can also be used for cell-replacement therapies
via autologous transplantation. On the other hand, the dis-
ease models established in this study hold the potential for
screening candidate drugs for combating XP diseases.
MATERIALS AND METHODS
Cells
Human XP patient ﬁbroblasts were purchased from Coriell Cell
Repository. XPA ﬁbroblast (GM00710) carries a homozygous
619C>T mutation resulting in a nonsense codon in exon 5 of XPA
gene. XPB ﬁbroblast (GM13026) is heterozygous for T>C
transversion in the XPB gene which results in a phenylalanine-99-to-
serine missense mutation. XPC ﬁbroblast (GM15709) has a
homozygous -9T>A mutation in intron 3 of the XPC gene. This
mutation is located in a splice lariat branch point sequence. PCR
analysis of ﬁbroblast cells detected an XPC mRNA isoform with
deletion of exon 4 (Khan et al., 2004). XPG ﬁbroblast (GM13371) is
b Figure 2. Generation and characterization of transgene-free
XP-iPSCs. (A) Summary of the generated iPSC colony number
after reprogramming of WT and XP mutant ﬁbroblasts.
(B) Phase-contrast images showing morphologies of WT,
XPA, XPB, XPC, XPG, XPV mutant patient ﬁbroblasts (top
panels) and ﬁbroblast-derived iPSCs (bottom panels).
(C) Immunostaining of WT and XP-iPSCs for NANOG, OCT4,
and SOX2. Scale bar, 50 μm. (D) qPCR analysis showing no or
little residual episomal vector element EBNA-1 in XP-iPSCs
and WT-iPSCs. Human ﬁbroblasts 4 days after electroporated
with pCXLE-hOCT3/4-shp53-F, pCXLE-hSK, and pCXLE-hUL
were included as positive control, and human H9 ESCs were
used as negative control. Data are shown as mean ± SD. n = 3.
(E) Karyotyping analysis of XP-iPSCs. (F) Immunostaining for
TUJ1 (ectoderm), α-SMA (mesoderm), and FOXA2 (endoderm)
of teratomas derived from XP-iPSCs. Nuclei were stained with
Hoechst 33342. Scale bar, 50 μm.
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identiﬁed with a 1 bp deletion in an AAA triplet at nucleotides
2170_2172 of the XPG gene resulting in subsequent frame shift.
XPV ﬁbroblast (GM03055) also has a nonsense mutation at
nucleotide 376 of the XPV gene (376C>T). The control ﬁbroblast
GM00038 was purchased from Coriell Cell Repository. All these
mutations in primary ﬁbroblasts or derived iPSCs were veriﬁed by
DNA sequencing. All ﬁbroblasts were maintained in high glucose
DMEM (Invitrogen) containing 15% FBS (Hyclone), 1% Glutamax
(Invitrogen), 1% non-essential amino acids (Invitrogen), 1% peni-
cillin/streptomycin (Invitrogen).
iPSCs generation and culture
XP patients speciﬁc iPSCs were generated by electroporation of
ﬁbroblasts with episomal vectors including pCXLE-hOCT3/4-shp53-
F, pCXLE-hSK and pCXLE-hUL as described (Liu et al., 2014; Okita
A
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Figure 3. Generation and characterization of XP-NSCs. (A) Schematic illustration of neural stem cell differentiation from iPSCs.
(B) Immunostaining of WTand XP-mutant NSCs for NESTIN and PAX6. Nuclei were stained with Hoechst 33342. Scale bar, 50 μm.
(C) Immunostaining of WT and XP-mutant neurons for TUJ1 and MAP2. Nuclei were stained with Hoechst 33342. Scale bar, 50 μm.
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Figure 4. XPA-mutant NSCs showed profound impairment of NER and hypersensitive to UV-induced apoptosis.
(A) Immunostaining of CPD in WT and XP-mutant NSCs cultured on coverslips in 24-well plate in the absence or presence of
1 J/m2 UV exposure. The images were taken 20 min or 48 h after UV irradiation, respectively. Nuclei were stained with Hoechst
33342. Scale bar, 50 μm. (B) Quantitative analysis of ﬂuorescence intensity of CPD in WT and XPA-mutant NSCs in the indicated
contexts. 60–100 nuclei were used for calculation. (C) Apoptosis analysis in WT and XPA-mutant NSCs 24 h after 1 J/m2 UV
treatment (quantitative data shown on the right). (D) Western blots showing PARP cleavage using anti-PARP (top blots) and anti-
cleaved PARP (middle blots) antibodies respectively in WTand XPA-mutant NSC 24 h after being exposed to 1 J/m2 UV. β-Actin was
used as a loading control. (E) Representative TUNEL staining in WTand XPA-mutant NSCs cultured on coverslips in 24-well plate in
the absence or presence of UV treatment (quantitative data shown on the right). Nuclei were stained with Hoechst 33342. Scale bar,
50 μm. Data are shown as mean ± SD. n = 3. For (C) and (D), cells were cultured on 6-well plates without coverslips. (F) Clonal
expansion analysis of WT and XPA mutant NSCs. Data are shown as mean ± SD. n = 3. (G) Cell migration analysis of WT and XPA
mutant NSCs. Data are shown as mean ± SD. n = 3.
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et al., 2011; Xu et al., 2014). All the derived iPSC lines were main-
tained on mitomycin C-treated MEF feeder cells in hESC medium
(Liu et al. 2011a, b, 2012; Zhang et al., 2015).
Generation and characterization of NSC
NSC differentiation and characterization were performed as previ-
ously described (Duan et al., 2015; Liu et al., 2012, 2014).
Neuronal differentiation
2.5 × 104 NSCs were seeded on a Matrigel-coated well of 6-well
plates. The next day, the culture medium was changed to differen-
tiation medium containing DMEM/F12, 1× N2, 1× B27, 200 μmol/L
ascorbic acid (Sigma), 400 μmol/L dbcAMP (Sigma), 10 ng/mL
GDNF (Peprotech) and 10 ng/mL of BDNF (Peprotech). Laminin
was added on the third day to promote differentiation. After 14 days
of differentiation the neurons were subjected to characterization or
cytotoxicity analysis.
Immunoﬂuorescence microscopy
Cells were ﬁxed with 4% paraformaldehyde for 30 min at room
temperature, washed with PBS, permeabilized in 0.4% Trion X-100
in PBS, and then blocked in 10% donkey serum (Jackson Immu-
noResearch Labs). After that, cells were incubated with primary
antibodies in blocking solution at 4°C overnight, followed by incu-
bation with corresponding secondary antibodies and Hoechst 33342
for 1 h at room temperature. The primary antibodies used include
anti-NANOG (Abcam, 21624), anti-OCT3/4 (Santa Cruz,5279), anti-
SOX2 (Santa Cruz,17320), anti-NESTIN (Millipore, MAB5326), anti-
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(Sigma, 4403), anti-FOXA2 (CST, 8186), anti-α-SMA (Sigma,
A5228).
CPD immunostaining
Cells were ﬁxed with 4% paraformaldehyde for 15 min at room
temperature, washed, and then permeabilized in 0.4% Trion X-100
in PBS. Following denature of cellular DNA with 2 mol/L HCl, cells
were blocked in 10% donkey serum, incubated with CPD antibody
(Cosmo Bio, TMD-2) and corresponding secondary antibodies.
Nuclei were stained with Hoechst 33342.
Teratoma formation and immunohistological analyses
Five million iPSCs were injected subcutaneously into NOD-SCID
mice. After 8–12 weeks, teratomas were excised, ﬁxed, dehydrated,
A
Day 0 Day 2
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Figure 5. XPA-iPSCs derived neurons showed increased susceptibility to UV-induced cell apoptosis. (A) Schematic
illustration of neuronal differentiation from NSCs. (B) CPD immunostaining in WT and XPA-mutant neurons cultured on coverslips in
24-well plate in the absence or presence of UV exposure. Nuclei were stained with Hoechst 33342. Scale bar, 50 μm. 60–100 nuclei
were used for calculation. (C) Representative images of TUNEL staining in WT and XPA-mutant neurons cultured on coverslips in
24-well plate in the absence or presence of UV exposure. Nuclei were stained with Hoechst 33342. Scale bar, 50 μm. Data are shown
as mean ± SD. 60–100 nuclei were used for calculation.
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embedded in O.C.T compound, sectioned, and analyzed by
immunostaining. All murine experiments were conducted in compli-
ance with animal protocols approved by the Chinese Academy of
Science Institutional Animal Care and Use Committee.
TUNEL
TUNEL analysis was performed using DeadEnd™ Fluorometric
TUNEL System kit (Promega). In short, cells were ﬁxed with 4%
paraformaldehyde at room temperature, permeabilized in 0.2% Trion
X-100 in PBS and pre-equilibrated with equilibration buffer, followed
by labeling DNA strand breaks with nucleotide mix (60 min at 37°C).
2× SSC was used to stop the reaction. DNA was stained with
Hoechst 33342.
Apoptosis
FACS-based cell apoptosis analysis was performed as previously
described (Liu et al., 2012).
Western blot analysis
For detecting the cleaved PARP in NSCs, cells were treated with UV
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Figure 6. Schematic illustration of disease modeling using XPA patient-speciﬁc iPSCs. Both NSCs and neurons derived from
XPA patient iPSCs showed compromised NER and increased susceptibility to DNA damage-induced apoptosis, which may contribute
to XP-associated neurological disorders.
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antibodies used were anti-PARP (CST, 9542), anti-cleaved PARP
(CST, 9541), anti-β-actin (Santa Cruz, 130301).
Statistical analysis
Data are presented as mean ± SD. The statistical signiﬁcance of
difference between groups was calculated using Student’s t test.
P > 0.05 (ns), P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***).
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